索万托 SOLV

Bryan C. Hanson, Chief Executive Officer and Director. Professional experience includes serving as Chief Executive Officer of Solventum Corporation from 2024 to the present, Chief Executive Officer of the 3M Health Care Business Group from 2023 to 2024, President and Chief Executive Officer of Zimmer Biomet Holdings, Inc. from 2017 to 2023, Executive Vice President at Medtronic plc from 2015 to 2017, Senior Vice President and Group President at Covidien plc from 2011 to 2015, and President of the Energy-based Devices business at Covidien plc from 2006 to 2011. Prior public company directorships include serving on the board of Walgreens Boots Alliance, Inc. from 2022 to 2025 and Zimmer Biomet Holdings, Inc. from 2017 to 2023.

Ms. Knight has served as Chief Commercial Officer of Solventum since November 2025. Ms. Knight has more than 30 years of experience in the healthcare industry. Prior to joining Solventum, she served as Chief Operating Officer of Baxter International, where she was responsible for global sales across three business segments, as well as research and development, supply chain, and medical and regulatory affairs. From 2019 to 2025, Ms. Knight held several senior leadership positions at Baxter, including interim Group President of its Medical Products and Therapies segment, Regional Division President, and Global Business Unit President for Medication Delivery, Clinical Nutrition and Acute Therapies. Earlier in her career, she held leadership roles in general management, upstream innovation, and commercial strategy at Medtronic plc, Covidien plc, Tyco International plc, and Kendall Healthcare Products Company. Ms. Knight earned her bachelor's degree in Biological Sciences from the University of Buffalo and completed the Executive Sales and Management program from the University of Chicago Booth School of Management. Ms. Knight currently serves on the board of directors of Waters Corporation.

Mr. McMillan has served as the Chief Financial Officer of Solventum since 2024 after serving as the Chief Financial Officer of 3M's Health Care Business Group since November 2023. Previously, Mr. McMillan served as Executive Vice President, Chief Financial Officer and Treasurer of Insulet, a medical device company, from March 2019 to November 2023. From January 2015 to February 2019, he was Chief Financial Officer and Vice President of Finance of the Minimally Invasive Therapies Group at Medtronic plc., a medical device company. From November 2006 to January 2015, prior to Medtronic's acquisition of Covidien plc, a medical device company, Mr. McMillan held a variety of leadership positions at Covidien, including Chief Financial Officer and Vice President of Finance of the Medical Devices Group & U.S., Chief Financial Officer and Vice President of Finance of the Surgical Solutions Business Unit, and Vice President Finance and Controller of the Respiratory and Monitoring Solutions Business Unit. Mr. McMillan started his career in accounting, audit, financial analysis and investor relations positions at various institutions. Mr. McMillan earned his Bachelor of Science in Business Administration from Merrimack College and an MBA from Bentley University McCallum Graduate School of Business. Mr. McMillan currently serves on the board of directors of Hologic Inc.

Ms. Kirberger has served as the Chief Corporate and Legal Affairs Officer and Corporate Secretary of Solventum since 2026, and was previously the Chief Legal Affairs Officer since 2024. Previously she served as the Chief Legal Affairs Officer of 3M's Health Care Business Group since November 2023. Previously, Ms. Kirberger was Executive Vice President, General Counsel and Corporate Secretary at Elanco, a pharmaceutical company in the animal health field, from June 2021 to November 2023, where she was responsible for the global strategy and operations of the legal function and had responsibility for Corporate Affairs, ESG and Enterprise Risk Management programs. Prior to joining Elanco, Ms. Kirberger held U.S., regional and global leadership roles within Fortune 500 life sciences companies, including as General Counsel and Corporate Secretary at Roche Diagnostics NA, a diagnostics company, from 2019 to 2021; and General Counsel and Chief Compliance Officer at Leica Microsystems GmbH, a global medical device manufacturer and subsidiary of Danaher Corporation, from 2017 to 2019. She also worked for the Novartis Group of Companies from 2006 to 2017 in different Novartis companies, including Gerber Products, Novartis Consumer Health, Novartis Pharmaceuticals and Sandoz International, where she was Global Head of Legal for Biopharma and before that, Global Chief Compliance Officer. Ms. Kirberger began her career as a securities litigator at Lowenstein Sandler in New Jersey. A native of Argentina, she earned her law degrees from Rutgers School of Law in Newark, New Jersey and the Catholic University of Argentina in Buenos Aires.

Ms. Landucci has served as the Chief Information and Digital Officer of Solventum since 2024. Prior to joining Solventum, Ms. Landucci was Chief Digital and Technology Officer at Haleon from July 2022 until April 2024, where she led the technical carveout from GSK to form a standalone consumer healthcare company. Prior to the carveout, she spent five years from July 2017 until July 2022 at GSK and previously spent a decade at Novartis in a variety of roles. The first eight years of her career were in consulting with Accenture. Ms. Landucci has served on the Board of Directors for Healthy Women, the leading independent, non-profit health information source for women in the U.S. Ms. Landucci earned her Bachelor of Arts in Environmental Studies from Gustavus Adolphus College.

Ms. Carrie S. Cox, Chairman of the Board. Professional experience includes serving as Executive Chairman of Organon & Co. from 2025 to the present, Chair of the Board at Humacyte, Inc. from 2013 to 2019, Board Member at Humacyte, Inc. from 2013 to 2021, Chief Executive Officer of Humacyte, Inc. from 2010 to 2018, Executive Vice President and President of the global pharmaceutical business at Schering-Plough Corporation from 2003 to 2009, and President of the global pharmaceutical business at Pharmacia Corporation from 1997 to 2003. Current public company directorships include serving on the board of Organon & Co. since 2021 and Texas Instruments Inc. since 2010, while prior public company directorships include Cardinal Health Inc. from 2009 to 2023 and Cartesian Therapeutics, Inc. from 2019 to 2025.

Mr. Glenn A. Eisenberg, Independent Director. Professional Experience: Laboratory Corporation of America Holdings Executive Vice President and Chief Financial Officer (2014 - 2024); The Timken Company Executive Vice President of Finance and Administration and Chief Financial Officer (2002 - 2014), United Dominion Industries (1990 - 2001); President and Chief Operating Officer (1999 - 2001). Prior Public Company Directorships: US Ecology, Inc.; Family Dollar Stores Inc.; Alpha Natural Resources Inc.; Perspecta Inc.

Ms. Karen J. May, Independent Director. Professional Experience: Mondelez International, Inc. (formerly Kraft Foods, Inc.) Executive Vice President and Chief Human Resources Officer (2005 - 2018); Baxter International Inc. Corporate Vice President and Chief Human Resources Officer (2001 - 2005), Vice President, Human Resources (1998 - 2001), Vice President, various roles (1990 - 1998); PricewaterhouseCoopers Certified Public Accountant (1980 - 1990). Current Public Company Directorships: Alcon, Inc. Prior Public Company Directorships: MB Financial, Inc. Other Directorships and Memberships: Ace Hardware Corporation (director).

Mr. Weiland, Independent Director. Professional Experience: C. R. Bard, Inc. President and Chief Operating Officer (2003 - 2017), Group President (1996 - 2003); Dentsply International, Inc. (1991 - 1996) Senior Vice President - North America. Prior Public Company Directorships: C. R. Bard, Inc.; Cardinal Health; Celgene Corporation; West Pharmaceutical Services.

Ms. DeVore, Independent Director. Professional Experience: Premier Inc. Chief Executive Officer (2013 - 2021), President (2013 - 2019), Served in a consulting capacity for Premier (2021 - 2023); Premier Healthcare Solutions President and CEO (2009 - 2013), Chief Operating Officer for a number of affiliated Premier entities (2003 - 2009). Current Public Company Directorships: Elevance Health, Inc.; Unum Group Prior Public Company Directorships: Premier, Inc. Other Directorships and Memberships: Advent Health System (director).

Mr. Carlos Alban, Independent Director. Professional Experience: AbbVie, Inc. Vice Chairman, Chief Commercial Officer (2018 - 2021), Executive Vice President, Commercial Operations (2013 - 2018); Abbott Laboratories, Inc. Senior Vice President, Proprietary Pharmaceutical Products, Global Commercial Operations (2011 - 2012), Senior Vice President, International Pharmaceuticals (2009 - 2011), Vice President, Pharmaceuticals, Western Europe and Canada Operations (2007 - 2009), Vice President, Pharmaceuticals, European Operations (2006 - 2007), Regional Director, Pharmaceuticals, Northern Europe (2004 - 2006), General Manager, Portugal (2002 - 2004), Other management and leadership roles (1986 to 2002). Prior public company directorships: SpringWorks Therapeutics, Inc. (2022 - 2025)

Ms. Wendell, Independent Director. Professional Experience: Perella Weinberg Partners Senior Advisor, Healthcare Investment Banking (2016 - 2019); McKinsey & Company Senior Advisor, Strategy and Corporation Finance (2015 - 2018); Covidien plc Senior Vice President of Strategy and Business Development (2006 - 2015). Current Public Company Directorships: AxoGen, Inc.; Baxter International, Inc.; Hologic, Inc. Ms. Wendell holds a Bachelor of Science in Mechanical Engineering from Lawrence Technological University and a Master of Science degree in Biomedical Engineering from the University of Illinois.

Mr. Darryl L. Wilson, Independent Director. Mr. Wilson has an MBA in Marketing from Indiana University. Professional Experience: The Wilson Collective President (2018 - present); General Electric Company (1992 - 2018) GE Power - Vice President, Commercial (2017 - 2018), Chief Commercial Officer, various divisions (2014 - 2017); British Petroleum North America (1985 - 1991). Current Public Company Directorships: NextEra Energy, Inc; Eaton Corporation; Primerica, Inc. Other Directorships and Memberships: Texas Children's Hospital - Finance and Public Policy Committees (chairman); The Kinkaid School Board of Trustees - Finance and Endowment Committees (chairman); Good Reason Houston (director), The Greater Cleveland Urban League (2024 - Present).

Ms. Mily, Independent Director. Professional Experience: The T1D Fund Chief Executive Officer (2025 - present); Bristol-Myers Squibb Executive Vice President, Strategy & Business Development (2020 - 2024); Barclays plc Managing Director (2010 - 2020); Thermo Fisher Scientific Senior Vice President (2009 - 2010); Goldman Sachs Group, Inc. (1993 - 2009) Managing Director, Senior Coverage Officer - Health Care. Other Directorships and Memberships: Ampersand Biomedicines (director).

Ms. Shirley Ann Edwards, Independent Director. Professional Experience: Ernst & Young Global Limited Global Client Service Partner (2017 - 2022), Partner (2002 - 2022). Current Public Company Directorships: Appian Corp.; Baker Hughes Company. Other Directorships and Memberships: Cumming Group (director); Girl Scouts of the Nation's Capital; Pamplin College of Business Advisory Council at Virginia Tech; Virginia Tech Foundation Board of Directors.

Dr. Harris earned a Bachelor of Science in Biology from the University of Houston, a Master of Medical Science from the University of Texas Medical Branch at Galveston, a Master of Business Administration from the University of Houston - Clear Lake, and a Doctor of Medicine from Texas Tech University Health Sciences Center School of Medicine. He completed a residency in internal medicine at the Mayo Clinic, a National Research Council Fellowship in endocrinology at the NASA Ames Research Center, and trained as a flight surgeon at the United States Air Force School of Aerospace Medicine. Dr. Harris is a Fellow of the American College of Physicians. Professional Experience: Versalius Ventures, Inc. Chief Executive Officer and Managing Partner (2002 - Present); NASA Former astronaut, mission specialist and payload commander, Logged more than 438 hours and first African American to walk in space. Current Public Company Directorships: RTX Corporation; U.S. Physical Therapy. Other Directorships and Memberships: Massachusetts Mutual Life Insurance Company (director); Astronaut Scholarship Foundation (director); Harris Foundation (board member); Texas Medical Center (board member). Current public company directorships: RTX Corporation (2021 - Present), U.S. Physical Therapy (2005 - Present).

On July 16, 2026, the Board of Directors of Solventum Corporation appointed Neil Zieselman to serve as Senior Vice President, Controller and Chief Accounting Officer of the Company, effective as of August 10, 2026. Mr. Zieselman, joins the Company from Surgery Partners, Inc., where he has served as its Senior Vice President, Corporate Finance and Controller since May 2022. Prior to Surgery Partners, Inc., Mr. Zieselman served Stryker Corporation as its Vice President, Finance Operations from April 2021 to May 2022, Senior Director, Finance Transformation from August 2019 to April 2021 and Senior Director, Finance and Group Controller, Orthopaedics Group from January 2017 to August 2019. Prior to joining Stryker Corporation, Mr. Zieselman held accounting and finance leadership roles at Covanta Holding Corporation, including Vice President and Chief Accounting Officer, Cendant Corporation and Avaya Inc. Mr. Zieselman began his career as an auditor with PricewaterhouseCoopers LLP. Mr. Zieselman is a licensed CPA and graduated Summa Cum Laude with a Bachelors of Science degree in Accounting from Rider University.

Ms. Gomez has served as the Chief Human Resources Officer of Solventum since 2024. Before joining Solventum, Ms. Gomez was Executive Vice President and Chief Human Resource Officer at Owens & Minor from July 2022 to December 2023. After starting as a Corporate Audit Manager in 1999, she spent more than 20 years at Cardinal Health in various roles of increasing responsibility, including most recently leading its Global HR Center of Excellence & HR Services team. She began her career in finance and worked with Prudential and General Motors. Ms. Gomez earned her Bachelor's degree in Business Administration and Management from the University of South Alabama.

Mr. Harrington has served as the Chief Supply Chain Officer of Solventum since 2024. Mr. Harrington spent 10 years at Medtronic, from November 2013 to November 2023, where he was most recently Senior Vice President, Global Operations Innovation responsible for shaping, transforming and innovating across the global operations and supply chain function. He also previously served as Vice President Global Operations for the Restorative Therapies Group and Neuromodulation business unit. Prior to joining Medtronic, he was Vice President of Global Manufacturing at Covidien. Mr. Harrington earned his Bachelor's degree in Business Administration from Kingston College.